FDA Approved a Total of 39 New Drugs in 2012 — Fifteen Year High

Research Driven Investing Provides Stocks Research on AEterna Zentaris and Oncolytics Biotech

Continue Reading

Nevada Casinos Revenues Total $10.86 Billion in 2012 — Third Consecutive Annual Increase

RDInvesting Provides Stock Research on Caesars Entertainment and MGM Resorts International

Continue Reading

Biotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year High

Research Driven Investing Provides Stocks Research on Alnylam and Arena

Continue Reading

U.S. Food and Drug Administration Approved 30% More Drugs in 2012

Research Driven Investing Provides Stocks Research on Optimer Pharmaceuticals and Santarus

Continue Reading

Federal Communications Commission Proposal of Free WiFi for the Public a Potential Obstacle for the Wireless Industry

Five Star Equities Provides Stock Research on Sprint Nextel and Leap Wireless

Continue Reading

Credit Companies Look to Benefit as Consumer Sentiment on the Rise Heading Into the New Year

Five Star Equities Provides Stock Research on Mastercard and Visa

Continue Reading

Biotech Companies Attractive Targets for Pharmaceutical Companies Looking to Replace Lost Revenues

Five Star Equities Provides Stock Research on OXiGENE and SIGA Technologies

Continue Reading

Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry-s Success

Research Driven Investing Provides Stocks Research on Amicus Therapeutics and Novavax

Continue Reading

Total Health Care Spending Projected Grow 70% by 2021

Research Driven Investing Provides Stocks Research on Mylan and Teva Pharmaceutical

Continue Reading

Consumer Borrowing Rises to the Highest Level on Record in December

Five Star Equities Provides Stock Research on American Express and Discover Financial Services

Continue Reading